Full Text View
Tabular View
No Study Results Posted
Related Studies
Crossover Bioequivalence Study of Tinidazole 500 mg Tablets Under Fed Conditions
This study has been completed.
Study NCT01591889   Information provided by Roxane Laboratories

First Received on May 1, 2012.   Last Updated on May 22, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Trichomoniasis
Additional conditions recognized in this trial
Trichomonas Infections
More general conditions related to this trial
Parasitic Diseases
Protozoan Infections
Interventions listed in this trial
Tinidazole
More general drug interventions related to this trial
Alkylating Agents
Anti-Infective Agents
Antiparasitic Agents
Antiprotozoal Agents
Antitrichomonal Agents
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
Roxane Laboratories


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services